Cargando…

Untargeted metabolomic profiling in a patient with glycogen storage disease Ib receiving empagliflozin treatment

Glycogen storage disease type Ib (GSD‐Ib) is a rare inborn error of glycogen metabolism uniquely associated with neutropenia and neutrophil dysfunction, causing severe infections, inflammatory bowel disease (IBD), and impaired wound healing. Recently, kidney sodium‐glucose co‐transporter‐2 (SGLT2) i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tallis, Eran, Karsenty, Cecile L., Grimes, Amanda B., Karam, Lina B., Elsea, Sarah H., Sutton, Vernon Reed, Rawls‐Castillo, Brandy L., Liu, Ning, Soler‐Alfonso, Claudia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley & Sons, Inc. 2022
Materias:	Case Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9259396/ https://www.ncbi.nlm.nih.gov/pubmed/35822097 http://dx.doi.org/10.1002/jmd2.12304

Ejemplares similares

Patient‐reported outcomes on empagliflozin treatment in glycogen storage disease type Ib: An international questionnaire study
por: Grünert, Sarah C., et al.
Publicado: (2023)

Two successful pregnancies and first use of empagliflozin during pregnancy in glycogen storage disease type Ib
por: Grünert, Sarah Catharina, et al.
Publicado: (2022)

The overall benefits of empagliflozin treatment in adult siblings with glycogen storage disease type Ib: one year experience
por: Bidiuk, Joanna, et al.
Publicado: (2022)

Improved inflammatory bowel disease, wound healing and normal oxidative burst under treatment with empagliflozin in glycogen storage disease type Ib
por: Grünert, Sarah C., et al.
Publicado: (2020)

Repurposing of Empagliflozin as a Possible Treatment for Neutropenia and Inflammatory Bowel Disease in Glycogen Storage Disease Type Ib: A Case Report
por: Makrilakis, Konstantinos, et al.
Publicado: (2022)

Crohn disease-like enterocolitis remission after empagliflozin treatment in a child with glycogen storage disease type Ib: a case report
por: Rossi, Alessandro, et al.
Publicado: (2021)

Crohn-like disease long remission in a pediatric patient with glycogen storage disease type Ib treated with empagliflozin: a case report
por: Calia, Margherita, et al.
Publicado: (2023)

Glycogen Storage Disease Ib and Severe Periodontal Destruction: A Case Report
por: Ma, Rui, et al.
Publicado: (2018)

Current understanding on pathogenesis and effective treatment of glycogen storage disease type Ib with empagliflozin: new insights coming from diabetes for its potential implications in other metabolic disorders
por: Maiorana, Arianna, et al.
Publicado: (2023)

The natural history of glycogen storage disease type Ib in England: A multisite survey
por: Halligan, Rebecca, et al.
Publicado: (2021)

Liver transplantation in glycogen storage disease type Ib: The role of SGLT2 inhibitors
por: Murko, Simona, et al.
Publicado: (2023)

Favorable outcome of empagliflozin treatment in two pediatric glycogen storage disease type 1b patients
por: Hexner-Erlichman, Zufit, et al.
Publicado: (2022)

Untargeted plasma metabolomics identifies broad metabolic perturbations in glycogen storage disease type I
por: Mathis, Tamara, et al.
Publicado: (2021)

Novel SLC37A4 Mutations in Korean Patients With Glycogen Storage Disease Ib
por: Choi, Rihwa, et al.
Publicado: (2017)

Infectious and digestive complications in glycogen storage disease type Ib: Study of a French cohort
por: Wicker, Camille, et al.
Publicado: (2020)

Clinical Remission of Severe Crohn’s Disease with Empagliflozin Monotherapy in a Pediatric Patient with Glycogen Storage Disease Type 1b
por: Collen, Lauren V., et al.
Publicado: (2023)

Mutation analysis of SLC37A4 in a patient with glycogen storage disease-type Ib
por: Zhang, Yamei, et al.
Publicado: (2019)

Clinical analysis and long-term treatment monitoring of 3 patients with glycogen storage disease type Ib
por: Du, Caiqi, et al.
Publicado: (2021)

A Novel Lipoprotein Lipase Mutation in an Infant With Glycogen Storage Disease Type-Ib and Severe Hypertriglyceridemia
por: Wang, Fengyu, et al.
Publicado: (2021)

Understanding the role of SGLT2 inhibitors in glycogen storage disease type Ib: the experience of one UK centre
por: Halligan, Rebecca K., et al.
Publicado: (2022)

Glycogen storage disease type Ia (GSDIa) but not Glycogen storage disease type Ib (GSDIb) is associated to an increased risk of metabolic syndrome: possible role of microsomal glucose 6-phosphate accumulation
por: Melis, Daniela, et al.
Publicado: (2015)

Finding balance between mature and immature neutrophils: The effects of empagliflozin in GSD‐Ib
por: Guerra, Fabiola, et al.
Publicado: (2023)

Untargeted Metabolomics for Autism Spectrum Disorders: Current Status and Future Directions
por: Glinton, Kevin E., et al.
Publicado: (2019)

Kidney and Metabolic Phenotypes in Glycogen Storage Disease Type-I Patients
por: Aoun, Bilal, et al.
Publicado: (2020)

Glycogen storage diseases: An update
por: Gümüş, Ersin, et al.
Publicado: (2023)

Neurological Characteristics of Pediatric Glycogen Storage Disease
por: Muzetti, Julio Henrique, et al.
Publicado: (2021)

Untargeted metabolomic analysis for the clinical screening of inborn errors of metabolism
por: Miller, Marcus J., et al.
Publicado: (2015)

Comparison of Untargeted Metabolomic Profiling vs Traditional Metabolic Screening to Identify Inborn Errors of Metabolism
por: Liu, Ning, et al.
Publicado: (2021)

Next-generation glycogen storage diseases
por: Derks, Terry G. J., et al.
Publicado: (2018)

Biomarkers in Glycogen Storage Diseases: An Update
por: Molares-Vila, Alberto, et al.
Publicado: (2021)

ON THE DIFFERING APPEARANCE OF INTRANUCLEAR AND CYTOPLASMIC GLYCOGEN IN LIVER CELLS IN GLYCOGEN STORAGE DISEASE
por: Sheldon, H., et al.
Publicado: (1962)

Untargeted metabolomics identifies unique though benign biochemical changes in patients with pathogenic variants in UROC1
por: Glinton, Kevin E., et al.
Publicado: (2018)

Determining mutations in G6PC and SLC37A4 genes in a sample of Brazilian patients with glycogen storage disease types Ia and Ib
por: Carlin, Marcelo Paschoalete, et al.
Publicado: (2013)

Empagliflozin Inhibits Hepatic Gluconeogenesis and Increases Glycogen Synthesis by AMPK/CREB/GSK3β Signalling Pathway
por: Yu, Xiaochen, et al.
Publicado: (2022)

Glycogen storage disease presenting as Cushing syndrome
por: Stefater, Margaret A., et al.
Publicado: (2019)

Impact of hematopoietic stem cell transplantation in glycogen storage disease type Ib: A single-subject research design using (13)C-glucose breath test
por: Turki, Abrar, et al.
Publicado: (2023)

Liver transplantation in glycogen storage disease type I
por: Boers, Susanna JB, et al.
Publicado: (2014)

Pulmonary Hypertension in Glycogen Storage Disease Type II
por: Li, Hui-Ping, et al.
Publicado: (2018)

Hepatic glycogen storage diseases are associated to microbial dysbiosis
por: Colonetti, Karina, et al.
Publicado: (2019)

Liver Transplantation for Glycogen Storage Disease Type IV
por: Liu, Min, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_l5na3hhrn8gcclfgv2rs8r0ie3